DZG Expert Center for Medicinal Chemistry
MedChem Platform


Imprint according to the following German regulations: § 6 TDG, § 10 MDStV Publisher

Helmholtz-Zentrum für Infektionsforschung GmbH
Inhoffenstraße 7 | 38124 Braunschweig | Germany 
Phone: +49 531 6181-0 | Fax: +49 531 6181-2655

Legal Form

The Helmholtz Centre for Infection Research is a Gesellschaft mit beschränkter Haftung (GmbH), which is similar to a limited liability company. 
Commercial Register Braunschweig, Germany
Registration Number: HRB 477

Persons authorised to represent

Prof Dr Dirk Heinz, Executive director
Silke Tannapfel, Administrative director
Inhoffenstraße 7 | 38124 Braunschweig | Germany 
Phone: +49 531 6181-0 | Fax: +49 531 6181-2655

Supervisory Board

MinDir'in Prof Dr Veronika von Messling (Chair)
Bundesministerium für Bildung und Forschung
MinDirig Rüdiger Eichel (Vice-Chairman)
Niedersächsisches Ministerium für Wissenschaft und Kultur
Christian Mees
Saarland - Staatskanzlei
Dr Andrea Niedzela-Schmutte
Bayerisches Staatsministerium für Wirtschaft, Landesentwicklung und Energie
Prof Dr Wolf-Dietrich Hardt
Eidgenössische Technische Hochschule Zürich
Prof Dr Caroline Kisker
Julius-Maximilians-Universität Würzburg
Prof Dr Luka Cicin-Sain
Helmholtz-Zentrum für Infektionsforschung 
Prof Dr Ingo Schmitz
Helmholtz-Zentrum für Infektionsforschung
Prof Dr Christopher Baum
Medizinische Hochschule Hannover
Prof Dr Jan Buer
Universitätsklinikum Essen
Prof Dr Petra Gastmeier
Charité - Universitätsmedizin
Prof Dr Christine Lang
MBCC Group Berlin

Value Added Tax Identification Number (according to § 27 a UStG)

DE 114815244

Responsible for site content

Helmholtz-Zentrum für Infektionsforschung GmbH
Susanne Thiele
Inhoffenstraße 7 | 38124 Braunschweig | Germany 
Phone: +49 531 6181-0 | Fax: +49 531 6181-1499

Corporate Governance

The Helmholtz Centre for Infection Research GmbH submits to the "Public Corporate Governance Code (PCGC)" of the federal government according to the memorandum of association. The Code recommends that the management and the supervisory board reports on the Company's corporate governance (Corporate Governance Report) on an annual basis.

The report refers to the PCGK as constituted on 30th of June 2009. Management and Supervisory Board declare that the recommendations of the Code are being complied essentially and will, deviations are explained in the respective report.

The Management Board and Supervisory Board declare that the Federal Public Corporate Governance Code as amended on 30 June 2009 has been complied with with reasonable deviations from the prescribed recommendations.

PCGK-Report 2011
PCGK-Report 2012
PCGK-Report 2013
PCGK-Report 2014
PCGK-Report 2015
PCGK-Report 2016
PCGK-Report 2017


The Helmholtz Centre for Infection Research does not take any responsibility for damages that occur in connection with any use of this website. The content of this website gets reviewed and updated on a regular basis if possible, a guarantee for correctness of any content can't be given in any case though.


We do not take any liability for any content of any external sites we link to. The content of external sites belongs to the sphere of responsibility of it's respective publishers. 
The data in this imprint is exclusively intended for getting in contact with us regarding content and legal issues. Any use of this data for advertisement is strictly prohibited.

Implementation Partner

Conception, design and technical implementation realised by:
Leuchtfeuer GmbH